Expression of the regulatory cell cycle proteins p21, p27, p14, p16, p53, mdm2, and cyclin E in bone marrow biopsies with acute myeloid leukemia. Correlation with patients' survival

被引:28
作者
Zolota, Vassiliki
Sirinian, Chaido
Melachrinou, Maria
Symeonidis, Argyrios
Bonikos, Dionysios S.
机构
[1] Univ Patras, Sch Med, Dept Pathol, GR-26110 Patras, Greece
[2] Univ Patras, Sch Med, Dept Internal Med, Div Hematol, GR-26110 Patras, Greece
关键词
acute mycloid leukemia; cell cycle protein; immunohistochemistry;
D O I
10.1016/j.prp.2007.01.010
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cell cycle control is a crucial event in normal hematopoiesis, and abnormalities of regulatory cell cycle genes have been found to contribute to the development of many hematologic malignancies. The present study investigates the immunohistochemical expression of seven essential cell cycle proteins (p21, p27, p14, p16, p53, mdm2, and cyclin E) in paraffin-embedded sections from 42 bone marrow biopsies obtained from an equal number of patients with newly diagnosed acute myeloid leukemia (AML). This study revealed (i) a high frequency of p53+/mdm2-/p21-phenotype, which is probably a result of p53 gene mutation and/or inhibition of mdm2 action by p14(ARF); (ii) expression of p27+/cyclinE-phenotype in most cases, suggesting that p27 may act as a potent cyclin-dependent kinase inhibitor; (iii) expression of p16 only in very few cases; and (iv) no relationship between the expression of any of the above proteins and survival as well as histologic subtype. (c) 2007 Elsevier GmbH. All rights reserved.
引用
收藏
页码:199 / 207
页数:9
相关论文
共 43 条
[1]   Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis [J].
Belinsky, SA ;
Nikula, KJ ;
Palmisano, WA ;
Michels, R ;
Saccomanno, G ;
Gabrielson, E ;
Baylin, SB ;
Herman, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11891-11896
[2]  
BOSARI S, 1995, VIRCHOWS ARCH, V427, P229
[3]   REGULATION OF TRANSCRIPTION FUNCTIONS OF THE P53 TUMOR-SUPPRESSOR BY THE MDM-2 ONCOGENE [J].
CHEN, JD ;
LIN, JY ;
LEVINE, AJ .
MOLECULAR MEDICINE, 1995, 1 (02) :142-152
[4]  
Chim CS, 2001, CANCER, V91, P2222, DOI 10.1002/1097-0142(20010615)91:12<2222::AID-CNCR1252>3.3.CO
[5]  
2-I
[6]   Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma [J].
Cordon-Cardo, C ;
Koff, A ;
Drobnjak, M ;
Capodieci, P ;
Osman, I ;
Millard, SS ;
Gaudin, PB ;
Fazzari, M ;
Zhang, ZF ;
Massague, J ;
Scher, HI .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (17) :1284-1291
[7]   Cell cycle and cancer: Critical events at the G1 restriction point [J].
DelSal, G ;
Loda, M ;
Pagano, M .
CRITICAL REVIEWS IN ONCOGENESIS, 1996, 7 (1-2) :127-142
[8]   Cyclin E in human cancers [J].
Donnellan, R ;
Chetty, R .
FASEB JOURNAL, 1999, 13 (08) :773-780
[9]  
Faderl S, 2000, CANCER, V89, P1976, DOI 10.1002/1097-0142(20001101)89:9<1976::AID-CNCR14>3.3.CO
[10]  
2-E